Applied Therapeutics Stock Analysis

Applied Stock Analysis Notes

About 83.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied Therapeutics recorded a loss per share of 0.24. The entity had not issued any dividends in recent years. Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. Applied Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people. For more info on Applied Therapeutics please contact the company at 212 220 9226 or go to https://www.appliedtherapeutics.com.

Applied Therapeutics Investment Alerts

Applied Therapeutics Upcoming and Recent Events

Applied Largest EPS Surprises

View All Earnings Estimates

Applied Stock Institutional Investors

Note, although Applied Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Applied Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 65.39 M.

Applied Profitablity

Management Efficiency

Applied Therapeutics has return on total asset (ROA) of (0.653) % which means that it has lost $0.653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8371) %, meaning that it created substantial loss on money invested by shareholders. Applied Therapeutics' management efficiency ratios could be used to measure how well Applied Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.28 in 2025. Return On Capital Employed is likely to drop to -1.84 in 2025. At this time, Applied Therapeutics' Total Current Liabilities is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 10.7 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 61.4 M in 2025.

Technical Drivers

As of the 20th of July, Applied Therapeutics shows the Mean Deviation of 5.7, risk adjusted performance of 0.0848, and Downside Deviation of 8.42. Applied Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Applied Therapeutics Price Movement Analysis

Applied Therapeutics Insider Trading Activities

Applied Therapeutics Outstanding Bonds

Applied Therapeutics Predictive Daily Indicators

Applied Therapeutics Forecast Models

Applied Therapeutics' time-series forecasting models are one of many Applied Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Applied Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Applied Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Applied shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Applied Therapeutics. By using and applying Applied Stock analysis, traders can create a robust methodology for identifying Applied entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Applied analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Applied analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Applied Therapeutics stock analysis indicators help investors evaluate how Applied Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Applied Therapeutics shares will generate the highest return on investment. By understating and applying Applied Therapeutics stock analysis, traders can identify Applied Therapeutics position entry and exit signals to maximize returns.

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.